Synteract Acquires Pediatric CRO KinderPharm to Further Strengthen its Pediatric Center of Development
Synteract, an innovative CRO partnering with biotech and pharma companies to bring new medicines to market, has acquired KinderPharm, a specialty pediatric CRO, focused on advancing pediatric drug development across all phases of clinical research. Like Synteract, KinderPharm has extensive experience in helping clients efficiently navigate the complex pediatric regulatory environments in the U.S. and Europe and provides advanced pharmacometric modeling and clinical trial simulation technologies coupled with juvenile formulation and toxicology services.
Pennsylvania-based KinderPharm is recognized for the only complete pediatrics clinical trial solution bolstered with advanced pharmacometric capabilities, including pharmacokinetic data analysis, PK/PD modeling, physiologically-based PK modeling, and population PK analysis, to facilitate efficient pediatric trial design and minimize patient numbers. Its strong relationships with its clients and investigative sites, as well as its expertise in working across a variety of pediatric indications and with hard-to-find patient populations is aligned with Synteract’s depth in pediatric drug development over the past 25 years.
“Pursuing our full commitment to pediatric development, we are now integrating Synteract’s existing base of experience and leadership with the focused knowledge and expertise that KinderPharm has provided its clients for many years,” says Synteract CEO Steve Powell. “Together we become the leading CRO for pediatric services, delivering a single source model for preclinical and clinical development, along with the specialized operational and logistical understanding required in working with children and their families.”
Joining the Synteract team as Senior Vice President, Pediatric Development and Scientific Innovation will be Dr. Martin Graham, founder and CEO of KinderPharm. He will assume global leadership for Synteract’s Center of Pediatric Development and will be joined by Lynne Georgopoulos, Vice President, Pediatric Development Americas and Synteract’s Dr. Martine Dehlinger-Kremer, Vice President, Pediatric Development Europe. With the extended team of pediatricians and PK/PD scientists, it will create one of the leading pediatric drug development CROs in the market.
Dr. Martin A. Graham, Ph.D., adds, “Given increased regulatory requirements for pediatric trials and the need to advance treatments for diseases that are unique to children, we are pleased to be combining our expertise with that of Synteract’s. As the leading pediatric CRO, we can offer global capabilities and unparalleled access to sites and patients. Our focus on the development of novel and rare pediatric drugs with advanced modeling and simulation, pediatric formulation and juvenile toxicology expertise provides our customers with unmatched research services.”
Synteract is a portfolio company of Amulet Capital Partners, LP. Financial terms are not being disclosed.
With employees across 21 countries, Synteract is an innovative, full-service CRO supporting biopharma companies across all phases of drug development to help bring new medicines to market. Synteract has conducted nearly 4,000 studies on six continents and in more than 60 countries, working with more than 26,000 investigative sites and nearly 750,000 patients. It has contributed to more than 240 product approvals. Synteract offers a notable depth of therapeutic expertise in oncology, dermatology, and neuro degenerative indications, as well as rare and orphan, pediatric, and immunotherapy studies. Connect on LinkedIn and Twitter.
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
H.I.G. Europe to Acquire Polyurethane Systems Business from Covestro17.6.2019 11:05:00 EEST | Tiedote
H.I.G. Capital, LLC ("H.I.G."), a leading global private equity investment firm with over €26 billion of equity capital under management, is pleased to announce that an affiliate has signed a definitive agreement to acquire the European Polyurethane Systems Business (the “Company”) in a carve-out transaction from Covestro AG. The transaction is subject to clearing by the relevant antitrust authorities with closing anticipated for the second half of 2019. The European Polyurethane Systems Business operates four systems houses in Germany, Denmark, the Netherlands and Spain. It employs approximately 250 full-time employees and generates annual sales of approximately €230 million. Systems houses develop and formulate tailor-made ready-to-use chemical blends for the production of a wide range of polyurethane products such as insulation materials, foams, shoe soles, and building materials. The Company serves a wide range of small- and mid-sized customers across Europe and will be led by Dr.
Norsk Titanium Announces Larger Capacity Rapid Plasma Deposition™ (RPD™) Machine17.6.2019 11:00:00 EEST | Tiedote
Officials with Norsk Titanium (Norsk) announced today the company has designed and is currently building a larger-scale Rapid Plasma Deposition™ (RPD™) machine. This new machine enables manufacturing of larger, more complex aircraft and engine components, at faster print speeds. The new RPD™ machine, the G-IVL, will use the same advanced RPD™ technology of Norsk’s current additive manufacturing process. Norsk’s patented RPD™ technology and equipment utilizes proprietary process controls to melt titanium wire with plasma torches, in an argon environment to produce near-net shape components for airframe and aircraft engine applications. The Norsk G-IVL machine will expand the printing envelope to 190cm by 40cm by 60cm. It will print double-sided, as well as single-sided components, of complex geometries and deposit material in excess of 8kg per hour. The resultant component will have the material qualities equivalent to forgings. “The G-IVL machine will significantly expand Norsk’s capab
TYAN Powers AI and HPC with 2nd Gen Intel® Xeon® Scalable Processor-based Server Platforms at ISC 201917.6.2019 11:00:00 EEST | Tiedote
TYAN®, an industry-leading server platform design manufacturer and a MiTAC Computing Technology Corporation subsidiary, is showcasing its new 2nd gen Intel® Xeon® Scalable processor-based platforms that are optimized for predictive analytics, machine learning, and HPC applications at ISC 2019 from June 17-19 at Messe Frankfurt, booth C-1250. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190617005020/en/ TYAN's Thunder HX Lineup Designed for AI Optimization and HPC Revolution (Photo: Business Wire) “The most demanding workloads including HPC, AI deep learning, data analytics, and multi-cloud infrastructure require maximum performance across compute, memory, storage, and network resources, “said Danny Hsu, Vice President of MiTAC Computing Technology Corporation's TYAN Business Unit. “2nd gen Intel Xeon Scalable processors provide a powerful foundation for TYAN server platforms that enables us to deliver performance enhanceme
Appointment of Mark Wood as Chairman of HomeServe Labs17.6.2019 11:00:00 EEST | Tiedote
HomeServe plc (“HomeServe”, “the Group”), the international home repairs and improvements business, is pleased to announce the appointment of Mark Wood CBE as non-Executive Chairman of HomeServe Labs, the unit within HomeServe that developed LeakBot. HomeServe Labs is the innovation arm of HomeServe which in 2016 launched LeakBot, a patented smart leak alarm that can detect leaks anywhere on a mains water system. Water leaks are one of the major causes of claims on home insurance policies across Western Europe and the US, and LeakBot is designed specifically to help insurance companies prevent water leak claims by catching the leaks early. Craig Foster, LeakBot CEO, said: "Mark Wood is a previous CEO of AXA and a veteran of the insurance industry. This experience will really benefit us as a B2B Insuretech. Mark is also a successful entrepreneur himself, and more recently added a huge amount of value to promising fintech start-ups like PensionBee. With Mark on board as our new Chairman,
L&T Technology Services Successfully Concludes Its Engineering The Change Campaign in Europe with 24-Hour Hackathon17.6.2019 10:30:00 EEST | Tiedote
L&T Technology Services Limited (NSE: LTTS), a leading global pure-play engineering services company, successfully concluded its Engineering the Change campaign in Munich with a 24-hour hackathon. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190617005290/en/ Caption - Left to right: Nitin Ugale from Sulzer | Gaurav Gupta from LTTS | Winners - Annabel Michel; Lars Konig; Atenea Fernandez Rozaoilla; Luca Setili; Till Neumeier | David Humphrey from ARC Advisory Group | Samir Bagga from LTTS | Nawida Martinozzi from Nokia (Photo: Business Wire) The company’s 16-day pan Europe initiative included a 3,000 km innovation-on-wheels drive covering Greater Manchester & Ellesmere Port (Cheshire) in the UK, Amiens & Paris in France and Eindhoven in Netherlands, culminating in Germany. A total of 230 visitors, including customers, analysts, industry experts, government officials, local authorities and engineering students attended the d
Philip Morris International Holds ‘Open Mic’ at 2019 Cannes Lions Festival17.6.2019 10:00:00 EEST | Tiedote
Philip Morris International (PMI) (NYSE: PM) announced today its return to the Cannes Lions International Festival of Creativity to engage with those who are actively creating and shaping meaningful change in the world. Working from its central theme of “Open Mic,” PMI will foster conversations around unexpected and provocative ideas, concepts and views with some of today’s boldest thinkers at the gathering known for bringing together the world’s most creative people to discuss new ideas, pioneering research and emerging technologies that help make and shape popular culture. “For PMI, attending Cannes is a surprising juxtaposition of what people may expect of us. But that’s what we need to do as we strive to unsmoke the world: be bold, cut through the haze and have conversations about the future,” said Jacek Olczak, chief operating officer for PMI. Returning to Cannes for the second year in a row, PMI will host a series of panels, one-on-one conversations and events that focus on encou
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme